Company Profile
Relay Therapeutics Stock Price, News & Analysis
- Ticker:
- RLAY
- Exchange:
- NASDAQ
- Sector:
- Biotechnology
- Location:
- Headquartered in the United States and listed on NASDAQ, Relay Therapeutics is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts.
Stock performance
17.44 USD (+0.93%)
Close
Last updated: June 23, 2026 at 00:00
3.8B USD
Market cap
Why the stock is moving
RLAY is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
Relay Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Relay Therapeutics is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts.
Business Model Characteristics
Relay Therapeutics follows a pipeline-led model where clinical readouts, filing updates, and program expansion determine how the market underwrites the story.
Position Within the Biotechnology Landscape
Compared with more mature healthcare names, Relay Therapeutics sits on the development side of the biotech landscape, where catalyst timing can reprice the stock quickly.
Future catalysts
Recent news
The five most recent feed items are shown below in reverse chronological order.
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Relay Therapeutics (RLAY)?
Relay Therapeutics (RLAY) most recently closed at 17.44 USD, a +0.93% move versus the previous session.
What is the market cap of Relay Therapeutics (RLAY)?
Relay Therapeutics currently has a market capitalization of 3.8B USD on BioPharmSignal.
What does Relay Therapeutics do?
Relay Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
On which exchange is RLAY stock listed?
Relay Therapeutics (RLAY) is associated with NASDAQ, Headquartered in the United States and listed on NASDAQ, Relay Therapeutics is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts., Biotechnology.
What is Relay?
Relay Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
Which conditions is Relay Therapeutics targeting with Relay?
Relay Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
What is Therapeutics?
Relay Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.